Overview

Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone

Status:
Completed
Trial end date:
2011-01-31
Target enrollment:
Participant gender:
Summary
Phase 1 study to determine the pharmacokinetic profile of NanoBUP Capsules to Suboxone.
Details
Lead Sponsor:
NanoSHIFT LLC
Nanotherapeutics, Inc.
Treatments:
Buprenorphine
Buprenorphine, Naloxone Drug Combination
Naloxone